251 related articles for article (PubMed ID: 23118517)
1. Ectonucleotidases in tumor cells and tumor-associated immune cells: an overview.
Bergamin LS; Braganhol E; Zanin RF; Edelweiss MI; Battastini AM
J Biomed Biotechnol; 2012; 2012():959848. PubMed ID: 23118517
[TBL] [Abstract][Full Text] [Related]
2. Ectonucleotidases in Inflammation, Immunity, and Cancer.
Haas CB; Lovászi M; Braganhol E; Pacher P; Haskó G
J Immunol; 2021 May; 206(9):1983-1990. PubMed ID: 33879578
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of NTPDase2 in gliomas promotes systemic inflammation and pulmonary injury.
Braganhol E; Zanin RF; Bernardi A; Bergamin LS; Cappellari AR; Campesato LF; Morrone FB; Campos MM; Calixto JB; Edelweiss MI; Wink MR; Sévigny J; Robson SC; Battastini AM
Purinergic Signal; 2012 Jun; 8(2):235-43. PubMed ID: 22038661
[TBL] [Abstract][Full Text] [Related]
4. Purinergic Signaling in Glioma Progression.
Braganhol E; Wink MR; Lenz G; Battastini AMO
Adv Exp Med Biol; 2020; 1202():87-108. PubMed ID: 32034710
[TBL] [Abstract][Full Text] [Related]
5. Ectonucleotidases in cancer and inflammation.
Stagg J; Thompson LF; Dwyer KM
J Biomed Biotechnol; 2012; 2012():951423. PubMed ID: 23125527
[No Abstract] [Full Text] [Related]
6. Purinergic signaling in glioma progression.
Braganhol E; Wink MR; Lenz G; Battastini AM
Adv Exp Med Biol; 2013; 986():81-102. PubMed ID: 22879065
[TBL] [Abstract][Full Text] [Related]
7. Biochemical analysis of ectonucleotidases on primary rat vascular smooth muscle cells and in silico investigation of their role in vascular diseases.
Bertoni APS; de Campos RP; Tamajusuku ASK; Stefani GP; Braganhol E; Battastini AMO; Wink MR
Life Sci; 2020 Sep; 256():117862. PubMed ID: 32473244
[TBL] [Abstract][Full Text] [Related]
8. Production of adenosine by ectonucleotidases: a key factor in tumor immunoescape.
Ghiringhelli F; Bruchard M; Chalmin F; Rébé C
J Biomed Biotechnol; 2012; 2012():473712. PubMed ID: 23133312
[TBL] [Abstract][Full Text] [Related]
9. Expression of ectonucleotidases in the prosencephalon of melatonin-proficient C3H and melatonin-deficient C57Bl mice: spatial distribution and time-dependent changes.
Homola M; Pfeffer M; Fischer C; Zimmermann H; Robson SC; Korf HW
Cell Tissue Res; 2015 Oct; 362(1):163-76. PubMed ID: 25959293
[TBL] [Abstract][Full Text] [Related]
10. Purinergic signaling in kidney disease.
Menzies RI; Tam FW; Unwin RJ; Bailey MA
Kidney Int; 2017 Feb; 91(2):315-323. PubMed ID: 27780585
[TBL] [Abstract][Full Text] [Related]
11. NTPDase and 5'-nucleotidase activities in physiological and disease conditions: new perspectives for human health.
Schetinger MR; Morsch VM; Bonan CD; Wyse AT
Biofactors; 2007; 31(2):77-98. PubMed ID: 18806312
[TBL] [Abstract][Full Text] [Related]
12. Extracellular ATP is Differentially Metabolized on Papillary Thyroid Carcinoma Cells Surface in Comparison to Normal Cells.
Bertoni APS; de Campos RP; Tsao M; Braganhol E; Furlanetto TW; Wink MR
Cancer Microenviron; 2018 Jun; 11(1):61-70. PubMed ID: 29455338
[TBL] [Abstract][Full Text] [Related]
13. Vascular CD39/ENTPD1 directly promotes tumor cell growth by scavenging extracellular adenosine triphosphate.
Feng L; Sun X; Csizmadia E; Han L; Bian S; Murakami T; Wang X; Robson SC; Wu Y
Neoplasia; 2011 Mar; 13(3):206-16. PubMed ID: 21390184
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of T cell and natural killer cell function by adenosine and its contribution to immune evasion by tumor cells (Review).
Hoskin DW; Mader JS; Furlong SJ; Conrad DM; Blay J
Int J Oncol; 2008 Mar; 32(3):527-35. PubMed ID: 18292929
[TBL] [Abstract][Full Text] [Related]
15. Extracellular vesicles in cancer immune responses: roles of purinergic receptors.
Graner MW
Semin Immunopathol; 2018 Sep; 40(5):465-475. PubMed ID: 30209547
[TBL] [Abstract][Full Text] [Related]
16. Cell-type specificity of ectonucleotidase expression and upregulation by 2,3,7,8-tetrachlorodibenzo-p-dioxin.
Wood E; Broekman MJ; Kirley TL; Diani-Moore S; Tickner M; Drosopoulos JH; Islam N; Park JI; Marcus AJ; Rifkind AB
Arch Biochem Biophys; 2002 Nov; 407(1):49-62. PubMed ID: 12392715
[TBL] [Abstract][Full Text] [Related]
17. History of ectonucleotidases and their role in purinergic signaling.
Zimmermann H
Biochem Pharmacol; 2021 May; 187():114322. PubMed ID: 33161020
[TBL] [Abstract][Full Text] [Related]
18. Expression of NTPDase1 and NTPDase2 in murine kidney: relevance to regulation of P2 receptor signaling.
Kishore BK; Isaac J; Fausther M; Tripp SR; Shi H; Gill PS; Braun N; Zimmermann H; Sévigny J; Robson SC
Am J Physiol Renal Physiol; 2005 May; 288(5):F1032-43. PubMed ID: 15632415
[TBL] [Abstract][Full Text] [Related]
19. CD73 on T Cells Orchestrates Cardiac Wound Healing After Myocardial Infarction by Purinergic Metabolic Reprogramming.
Borg N; Alter C; Görldt N; Jacoby C; Ding Z; Steckel B; Quast C; Bönner F; Friebe D; Temme S; Flögel U; Schrader J
Circulation; 2017 Jul; 136(3):297-313. PubMed ID: 28432149
[TBL] [Abstract][Full Text] [Related]
20. Purinergic Signaling in the Hallmarks of Cancer.
Campos-Contreras ADR; Díaz-Muñoz M; Vázquez-Cuevas FG
Cells; 2020 Jul; 9(7):. PubMed ID: 32635260
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
